Compounds > falirytmin
Page last updated: 2024-12-08

falirytmin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Falirytmin: structure; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID173643
MeSH IDM0060053

Synonyms (12)

Synonym
brn 2313825
n,n'-bis-(3-(2'-aethoxyphenoxy)-2-hydroxypropyl)-aethylendiamin [german]
2-propanol, 1,1'-(1,2-ethanediyldiimino)bis(3-(2-ethoxyphenoxy)-
i 902
falirytmin
n,n'-bis-(3-(2'-ethoxyphenoxy)-2-hydroxypropyl)-ethylenediamine
1,1'-(1,2-ethanediyldiimino)bis(3-(2-ethoxyphenoxy)-2-propanol)
1-(2-ethoxyphenoxy)-3-[2-[[3-(2-ethoxyphenoxy)-2-hydroxypropyl]amino]ethylamino]propan-2-ol
n,n'-bis-(3-(2'-aethoxyphenoxy)-2-hydroxypropyl)-aethylendiamin
58774-82-6
DTXSID60974293
1,1'-(ethane-1,2-diyldiazanediyl)bis[3-(2-ethoxyphenoxy)propan-2-ol]

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" An average biological half-life of 18."( Relationship between the pharmacokinetics of a short-acting antiarrhythmic drug and its effects: studies with Falirytmin.
Förster, W; Hafemeister, G; Machill, K; Sziegoleit, W; Weiss, M, 1980)		0.47
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
ConditionIndicatedRelationship StrengthStudiesTrials